Cargando…
Evaluation of treatment plan by three-period pulses of high-dose dexamethasone among patients with primary immune thrombocytopenia on platelet count response and adverse events: A randomized Clinical trial
BACKGROUND: Primary immune thrombocytopenia (ITP) decreases platelet count as well as increases the risk of bleeding due to platelet destruction in an autoimmune disorder. For many years, prednisone (PDN) has been the standard first-line treatment in ITP practical guidelines. The current randomized...
Autores principales: | Sadeghi, Alireza, Hosseini, Seyyideh Forough, Jouzdani, Saeid Rezaei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698390/ https://www.ncbi.nlm.nih.gov/pubmed/33273933 http://dx.doi.org/10.4103/jrms.JRMS_257_19 |
Ejemplares similares
-
Giant left anterior descending coronary artery aneurysm in an adult male patient with ST elevation myocardial infarction
por: Sadeghi, Mohsen Mirmohammad, et al.
Publicado: (2016) -
Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
por: Bury, Loredana, et al.
Publicado: (2021) -
Sialic acid and platelet count regulation: Implications in immune thrombocytopenia
por: Lee‐Sundlov, Melissa M., et al.
Publicado: (2022) -
Effect of linezolid on platelet count in critically ill patients with thrombocytopenia
por: Tatsumi, Hiroomi, et al.
Publicado: (2023) -
Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
por: Li, Na, et al.
Publicado: (2021)